Eyepoint Pharmaceuticals shares owned by UBS Group
Quarter-by-quarter ownership of Eyepoint Pharmaceuticals (EYPT) shares owned by UBS Group
from 13F filings
Historical chart of UBS Group investment in Eyepoint Pharmaceuticals
Tip: Access up to 7 years of quarterly data
All positions including Eyepoint Pharmaceuticals held by UBS Group consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Eyepoint Pharmaceuticals by UBS Group
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $5.0M | 350k | 14.24 |
| 2025-06-30 | $1.2M | 126k | 9.41 |
| 2025-03-31 | $2.1M | 387k | 5.42 |
| 2024-12-31 | $4.2M | 570k | 7.45 |
| 2024-09-30 | $3.2M | 401k | 7.99 |
| 2024-06-30 | $1.7M | 190k | 8.70 |
| 2024-03-31 | $9.4M | 457k | 20.67 |
| 2023-12-31 | $13M | 574k | 23.11 |
| 2023-09-30 | $4.2M | 527k | 7.99 |
| 2023-06-30 | $780k | 90k | 8.70 |
| 2023-03-31 | $2.1k | 700 | 2.94 |
| 2022-12-31 | $2.5k | 700 | 3.50 |
| 2022-09-30 | $5.0k | 600 | 8.33 |
| 2022-06-30 | $5.0k | 600 | 8.33 |
| 2022-03-31 | $18k | 1.5k | 11.67 |
| 2021-12-31 | $395k | 32k | 12.22 |
| 2021-09-30 | $10k | 1.0k | 10.00 |
| 2021-06-30 | $18k | 1.7k | 10.00 |
| 2021-03-31 | $5.0k | 501 | 10.00 |
| 2020-12-31 | $3.0k | 500 | 6.00 |